DK0445731T3 - Azabicyclo- og azacyclooxim- og -amin-choliner-giske midler og farmaceutisk acceptable salte deraf - Google Patents

Azabicyclo- og azacyclooxim- og -amin-choliner-giske midler og farmaceutisk acceptable salte deraf

Info

Publication number
DK0445731T3
DK0445731T3 DK91103308.2T DK91103308T DK0445731T3 DK 0445731 T3 DK0445731 T3 DK 0445731T3 DK 91103308 T DK91103308 T DK 91103308T DK 0445731 T3 DK0445731 T3 DK 0445731T3
Authority
DK
Denmark
Prior art keywords
azabicyclo
amine
oximes
azacyclooxime
pharmaceutically acceptable
Prior art date
Application number
DK91103308.2T
Other languages
Danish (da)
English (en)
Inventor
Anthony Jerome Thomas
Haile Tecle
David Jeffrey Lauffer
Walter Hamilton Moos
Michael Raymond Pavia
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK0445731T3 publication Critical patent/DK0445731T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK91103308.2T 1990-03-06 1991-03-05 Azabicyclo- og azacyclooxim- og -amin-choliner-giske midler og farmaceutisk acceptable salte deraf DK0445731T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48891690A 1990-03-06 1990-03-06
US59164790A 1990-10-02 1990-10-02
US64147891A 1991-01-22 1991-01-22

Publications (1)

Publication Number Publication Date
DK0445731T3 true DK0445731T3 (da) 1996-04-29

Family

ID=27413829

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91103308.2T DK0445731T3 (da) 1990-03-06 1991-03-05 Azabicyclo- og azacyclooxim- og -amin-choliner-giske midler og farmaceutisk acceptable salte deraf

Country Status (19)

Country Link
EP (1) EP0445731B1 (pt)
JP (3) JP3223192B2 (pt)
KR (1) KR0182268B1 (pt)
CN (1) CN1054601A (pt)
AT (1) ATE132868T1 (pt)
AU (1) AU630542B2 (pt)
CA (1) CA2037541C (pt)
DE (1) DE69116185T2 (pt)
DK (1) DK0445731T3 (pt)
ES (1) ES2082024T3 (pt)
FI (1) FI95705C (pt)
GR (1) GR3019226T3 (pt)
HK (1) HK1005025A1 (pt)
HU (1) HUT57210A (pt)
IE (1) IE70322B1 (pt)
IL (1) IL97266A0 (pt)
NO (1) NO177711C (pt)
NZ (1) NZ237300A (pt)
PT (1) PT96946B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5306718A (en) * 1990-03-06 1994-04-26 Warner-Lambert Company Oxime and amine substituted azabicyclo and azocyclo muscarinic agonists and methods of treatment
US5296570A (en) * 1990-08-03 1994-03-22 The Dow Chemical Company Curable mixtures of mesogenic epoxy resins and mesogenic polyamines and cured compositions
US5264502A (en) * 1990-08-03 1993-11-23 The Dow Chemical Company Diamino-alpha-alkylstilbene curing agents for epoxy resins
US5268434A (en) * 1990-08-03 1993-12-07 The Dow Chemical Company Diamino-alpha-alkylstilbenes as epoxy resin curing agents
US5276184A (en) * 1990-08-03 1994-01-04 The Dow Chemical Company Sulfonamide compounds containing mesogenic moieties
US5414125A (en) * 1990-08-03 1995-05-09 The Dow Chemical Company Diamino-alpha-alkylstilbenes
US5262509A (en) * 1990-08-03 1993-11-16 The Dow Chemical Company Mesogenic glycidyl amines
US5391651A (en) * 1990-08-03 1995-02-21 The Dow Chemical Company Curable mixtures of mesogenic epoxy resins and mesogenic polyamines and cured compositions
GB2258652A (en) * 1991-08-15 1993-02-17 Merck Sharp & Dohme Pharmaceutically useful azabicyclic oxime ethers
WO1993008191A1 (en) * 1991-10-15 1993-04-29 Warner-Lambert Company Azabicyclo oxime and amine cholinergic agents and methods of treatment
ZA931109B (en) * 1992-03-04 1993-09-22 Akzo Nv Tetrahydropyrimidine derivatives.
US5298575A (en) * 1992-11-30 1994-03-29 The Dow Chemical Company Nitro group terminated mesogenic epoxy resin adducts
US5552407A (en) * 1993-06-11 1996-09-03 New York University Medical Center Anhydroecgonine compounds and their use as anticholinergic agents
US5514812A (en) * 1994-06-10 1996-05-07 Warner-Lambert Company Preparation of stereochemically pure oximes with muscarinic activity
DE59605367D1 (de) * 1995-12-20 2000-07-06 Eckhart Pein Verwendung des alpha,alpha-diphenylessigsäure-4-(n-methyl-piperidyl)esters als spasmoanalgetikum
WO1998032758A1 (en) * 1997-01-27 1998-07-30 Warner-Lambert Company Single pot process for producing (z)-azabicyclo oxime ethers
US5733912A (en) * 1997-02-19 1998-03-31 Abbott Laboratories 7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission
AU2206599A (en) * 1997-12-23 1999-07-12 Alcon Laboratories, Inc. Oximino-piperidine, -pyrrolidine and -azepine derivatives, their preparation andtheir use as muscarinic receptor (ant-)agonists
JP2003508412A (ja) * 1999-08-27 2003-03-04 アベンティス・クロップサイエンス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 農薬としてのアザビシクロおよびアザシクロオキシム、並びにアミン化合物
KR100465277B1 (ko) * 2002-01-24 2005-01-13 한국과학기술연구원 신규한 옥심계 아자 두 고리 화합물 및 그 제조방법
DE10302912A1 (de) * 2003-01-24 2004-08-12 Bayer Faser Gmbh Chlorbeständige Elastanfasern

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2019536A1 (de) * 1970-04-23 1971-11-11 Basf Ag Oximcarbamate
DE2552176A1 (de) * 1975-11-21 1977-06-02 Hoechst Ag Neue piperidin-derivate, ihre herstellung und verwendung
US4353922A (en) * 1981-03-13 1982-10-12 Syntex (U.S.A.) Inc. Anticholinergic bronchodilators

Also Published As

Publication number Publication date
FI911083A0 (fi) 1991-03-04
ATE132868T1 (de) 1996-01-15
CA2037541C (en) 2001-10-02
CA2037541A1 (en) 1992-08-11
NZ237300A (en) 1993-12-23
IE70322B1 (en) 1996-11-13
GR3019226T3 (en) 1996-06-30
JP2000239166A (ja) 2000-09-05
HU910712D0 (en) 1991-09-30
JP2000212163A (ja) 2000-08-02
PT96946B (pt) 1998-07-31
PT96946A (pt) 1991-10-31
FI911083A (fi) 1991-09-07
DE69116185D1 (de) 1996-02-22
CN1054601A (zh) 1991-09-18
AU630542B2 (en) 1992-10-29
FI95705B (fi) 1995-11-30
AU7260291A (en) 1991-09-12
JP3223192B2 (ja) 2001-10-29
NO910860D0 (no) 1991-03-05
HUT57210A (en) 1991-11-28
EP0445731A1 (en) 1991-09-11
NO910860L (no) 1991-09-09
ES2082024T3 (es) 1996-03-16
DE69116185T2 (de) 1996-05-15
NO177711B (no) 1995-07-31
EP0445731B1 (en) 1996-01-10
FI95705C (fi) 1996-03-11
IL97266A0 (en) 1992-05-25
HK1005025A1 (en) 1998-12-18
IE910731A1 (en) 1991-09-11
JPH04217660A (ja) 1992-08-07
KR910016728A (ko) 1991-11-05
KR0182268B1 (ko) 1999-05-01
NO177711C (no) 1995-11-08

Similar Documents

Publication Publication Date Title
DK0445731T3 (da) Azabicyclo- og azacyclooxim- og -amin-choliner-giske midler og farmaceutisk acceptable salte deraf
NO953447L (no) Nye 4-aminopyridiner, fremgangsmåte for deres fremstilling samt legemidler inneholdende disse
ZA944739B (en) Amide and urea derivatives having anti-hypercholesteremic activity their preparation and their therapeutic uses
DE68913327D1 (de) Spirocyclische Verbindungen mit zwei Heteroatome enthaltenden fünfgliedrigen Ringen.
FI941699A0 (fi) Atsabisyklo-aryyliasetyleeni- ja arylenyynioksiimit kolinenergisina aineina ja hoitomenetelmät
DE69427517D1 (de) Tetracyclische kondensierte heterocyclische Verbindungen zur Behandlung von seniler Demenz
ES2109216T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica con actividad relajante muscular de accion central.
DE69315363D1 (de) Amphotere tricyclische Verbindungen als antihistaminische und antiallergische Mittel